VVM
Versant Venture Management Portfolio holdings
AUM
$82.1M
This Quarter Return
+51.11%
1 Year Return
-26.22%
3 Year Return
+73.87%
5 Year Return
-1.11%
10 Year Return
+1,578.11%
AUM
$98.7M
AUM Growth
+$98.7M
(-29%)
Cap. Flow
-$67.5M
Cap. Flow
% of AUM
-68.39%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
1
Closed
2
Top Buys
No buys this quarter
Top Sells
| 1 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$44.4M |
| 2 |
Glaukos
GKOS
|
$16M |
| 3 |
BITI
BIOTIE THERAPIES CORP SPONSORED ADR
BITI
|
$7.09M |
Sector Composition
| 1 | Healthcare | 95.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Glaukos
GKOS
$5.5B
| $75.4M | 76.45% | 2,586,985 -549,247 | -18% | -$16M |
|
2
Ocular Therapeutix
OCUL
$2.12B
| $11M | 11.11% | 2,215,384 | – | – |
|
|
CLVS
3
DELISTED
Clovis Oncology, Inc.
CLVS
| $5.59M | 5.66% | 407,416 | – | – |
|
|
AKAO
4
DELISTED
Achaogen, Inc.
AKAO
| $4.86M | 4.92% | 1,281,152 | – | – |
|
|
CBAY
5
DELISTED
Cymabay Therapeutics
CBAY
| $1.82M | 1.85% | 1,048,601 | – | – |
|
|
FPRX
6
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| – | – | -1,092,152 | Closed | -$44.4M |
|
|
BITI
7
DELISTED
BIOTIE THERAPIES CORP SPONSORED ADR
BITI
| – | – | -268,672 | Closed | -$7.09M |
|